NeuBase Therapeutics Stock Forecast - Market Facilitation Index
| NBSEDelisted Stock | USD 1.62 0.17 9.50% |
NeuBase Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NeuBase Therapeutics stock prices and determine the direction of NeuBase Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NeuBase Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
NeuBase |
| Check NeuBase Therapeutics Volatility | Backtest NeuBase Therapeutics | Information Ratio |
NeuBase Therapeutics Trading Date Momentum
| On November 30 2024 NeuBase Therapeutics was traded for 1.62 at the closing time. The top price for the day was 1.83 and the lowest listed price was 1.60 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not cause price change. The trading delta at closing time against the current closing price is 10.49% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare NeuBase Therapeutics to competition
View NeuBase Therapeutics Related Equities
| Risk & Return | Correlation |
NeuBase Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns.
NeuBase Therapeutics Risk Indicators
The analysis of NeuBase Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeuBase Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neubase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.27 | |||
| Standard Deviation | 6.12 | |||
| Variance | 37.5 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in NeuBase Stock
If you are still planning to invest in NeuBase Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeuBase Therapeutics' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |